Patrys Limited (ASX:PAB)
Australia · Delayed Price · Currency is AUD 0.0330
0.00 (0.00%)
Jan 30, 2026, 3:55 PM AEST
Patrys Market Cap
Patrys has a market cap or net worth of 11.24 million as of January 30, 2026. Its market cap has increased by 56.15% in one year.
Market Cap
11.24M
Enterprise Value
10.50M
Revenue
828.54K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since July 13, 2007, Patrys's market cap has decreased from 97.06M to 11.24M, a decrease of -88.42%. That is a compound annual growth rate of -10.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 11.24M | 17.86% |
| Dec 31, 2025 | 9.54M | 15.93% |
| Dec 31, 2024 | 8.23M | -50.00% |
| Dec 29, 2023 | 16.46M | -70.36% |
| Dec 30, 2022 | 55.54M | -27.00% |
| Dec 31, 2021 | 76.08M | 75.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurotech International | 19.44M |
| Tissue Repair | 18.44M |
| AdAlta | 11.48M |
| Immuron | 11.39M |
| Chimeric Therapeutics | 11.05M |
| Biotron | 9.64M |
| Bio-Gene Technology | 9.46M |
| Invex Therapeutics | 9.02M |